Parkinson’s Disease

It is a progressive and chronic disorder, caused by death or malfunctioning of neurons, genetic mutation leading to decreased level of dopamine secretion. Associated effects are anxiety; depression, stress, ageing and neurodegenerative disorders, disease diagnostics, drug designing and therapeutics are the research areas.

The combined direct and indirect cost of Parkinson’s, including treatment, social security payments and lost income from inability to work, is estimated to be nearly $25 billion per year in the United States alone.Medication costs for an individual person with PD average $2,500 a year, and therapeutic surgery can cost up to $100,000 dollars per patient.

Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disease most widely recognized for the profound degeneration of mid-brain dopamine nigrostriatal neurons linked to serious motor symptoms. Oral dopaminergic pharmaceuticals are effective in controlling these symptoms at early disease stages.

  • Impact of genetic mutations
  • Interdependent disorders such as neurodegenerative disorders and ageing
  • Anxiety, depression and stress level in Parkinson’s
  • Approaches involved in diagnostics
  • Drug desigining and therapeutics

Related Conference of Parkinson’s Disease

July 11-13, 2016

6th Asia-Pacific Pharma Congress

Kuala Lumpur, Malaysia
July 14-15, 2016

5th Global Pharmacists Annual Meeting

Brisbane, Australia
July 14-15, 2016

International Pharmacy Conference

Philadelphia, PA, USA
July 18-20, 2016

5th Annual European Pharma Congress

Berlin,Germany
August 08-10, 2016

3rd World Congress on Pharmacology

Birmingham, UK
August 11-13, 2016

International Conference on Anatomy and Physiology

Holiday Inn Birmingham City Centre, Birmingham,UK
September 28-30, 2016

6th Pharmacovigilance Congress

Toronto, Ontario, Canada
August 22-24, 2016

2nd International Conference on Clinical Trials

Philadelphia, Pennsylvania, USA
August 22-24, 2016

7th Annual Global Pharma Summit

New Orleans, Louisiana, USA
September 05-07, 2016

Drug Formulation & Bioavailability Congress

Beijing, China
September 14-16, 2016

4th Global Experts Meeting on Neuropharmacology

San Antonio, Texas, USA
October 03-04, 2016

International Conference on Pain Research & Management

Vancouver, Canada
October 10-12, 2016

8th Annual Pharma Middle East Congress

Dubai, UAE
Oct 31- Nov 02, 2016

5th International Conference on Forensic Research & Technology

San Francisco, California, USA
Nov 07-09, 2016

4th International Conference on Clinical Pharmacy

Las Vegas, Nevada, USA
Nov 07-09, 2016

World Pharma Congress

Las Vegas, Nevada, USA
March 6-8, 2017

8th Global Pharmacovigilance Summit

Melbourne, Australia
March 27-29, 2017

International Conference on Medical Devices

Orlando, USA
May 25-26, 2017

World Congress on Biotherapeutics

Mexico, USA
June 12-14, 2017

World Congress on Controlled/ Sustained Release Formulations

Amsterdam, Netherlands
August 14-16, 2017

8th Asian Biosimilars Congress

Japan
Sep 25-27, 2017

Annual Pharmaceutical Analysis Conference

Vienna, Austria
October 23-25, 2017

International Conference on Biotech Pharmaceuticals

Paris, France

Parkinson’s Disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in